Shelter Pharma Limited has received an international export order from Berlin International Company in the normal course of business. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026.

Order Details

  • Entity Awarding Order: Berlin International Company
  • Nature of Order: Purchase orders for supply of Nutraceutical products
  • Specific Product: D3 CURE 50 ML
  • Quantity: 3500 units
  • Unit Price: USD 2.90
  • Total Order Value: USD 10,150 (equivalent to ₹9,72,360.86 - Rupees Nine Lakhs Seventy-Two Thousand Three Hundred and Sixty and Eighty-Six Paise only)
  • Order Type: International entity, international transaction
  • Execution Timeline: To be executed within mutually agreed timelines as per purchase order schedule

Transaction Characteristics

  • Business Nature: Normal course of business
  • Related Party Status: Not a related party transaction
  • Promoter Interest: No interest by promoter/promoter group/group companies in the entity awarding the order

Strategic Context

The receipt of this export order aligns with the company's strategic focus on diversifying its revenue base and strengthening its presence in international markets. The company emphasizes that this development supports its efforts to broaden market reach across the global nutraceutical sector. The order is expected to contribute to business and revenue growth upon execution and further expand the international customer base.

Company Capabilities Mentioned

The disclosure highlights the company's research and development capabilities that enable development and offering of products in line with evolving market and customer requirements. The association with overseas customers provides opportunity to utilize R&D expertise for developing innovative products suited to international market requirements.

Future Focus Areas

The company states it will continue to focus on research and development, product quality, and timely execution while exploring opportunities to further expand presence across global nutraceutical and healthcare markets.